KKR Income Opportunities Fund KIO 深 滬
等待開盤 10-11 09:30:00 美东时间
12.04
-0.308
-2.50%
華盛通- 最 高12.345
- 今 開12.345
- 成交量 100.41万股
- 最 低 12.03
- 昨 收 12.3485
- 總市值 3.27亿
- 52周最高 12.9485
- 市盈率 靜 4.95
- 換手率 3.70%
- 52周最低 9.961
- 委 比 22.70%
- 總股本 2714.57万
- 歷史最高 13.631
- 量 比 3.01
- 振 幅 2.55%
- 歷史最低 0.6841
- 每 手 1
- 風險率 0.56%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多TMT Notes | AI半导体/英伟达/Marvell/美光/存储/设备
（来源：纳指弹幕组） *原则: 定期更新, 专注美股TMT及配套供应链；仅转述归纳外资研报观点，不展示研报原文，保护研报版权；无精力做知识星球, 不...
09-28 20:45
KIO Data Centers积极支持太空数据存储
墨西哥及拉丁美洲的数字基础设施提供商KIO Data Centers宣布与天基数据存储先驱Lonestar Data Holdings建立战略联盟。此次合作开创...
09-22 11:13
KKR Income Opportunities Fund declares $0.1215 dividend
KKR Income Opportunities Fund (NYSE:KIO) declares $0.1215/share monthly dividend, in line with previous. Forward yield 11.6% Payable Oct. 31; for shareholders of record Oct. 10; ex-div Oct. 10. Payabl...
09-12 20:46
质变开启：潍柴动力(000338.SZ/2338.HK)2025中报里的转型与突围
2025年上半年，中国商用车行业在复杂多变的宏观环境中展现出强大的发展韧性，结束了此前连续几年的低迷期。从销量数据、政策支持到结构性调整，多维度指标均呈现显著回...
09-02 09:13
6家中国药企进入全球TOP50！云南白药、中生、华东、百济、恒瑞、石药
作者 | 晓琳 编辑 | 郑瑶 国内药企上榜数量创历史新高，云南白药、中国生物、华东医药、百济神州、恒瑞医药、石药集团。 01 全球制药企业50强 中国6家药...
08-20 18:53
KIOCL Limited Exits Export Oriented Unit Scheme
The latest announcement is out from KIOCL Ltd ( ($IN:KIOCL) ). KIOCL Limited ha...
08-11 15:36
Kiora Pharmaceuticals GAAP EPS of -$0.54
Kiora Pharmaceuticals press release (NASDAQ:KPRX): Q2 GAAP EPS of -$0.54. Ended the quarter with $20.7 million in cash, cash equivalents and short-term investments, along with $2.4 million in collabor...
08-08 19:09
IKIO Technologies Releases Investor Presentation to Outline Growth Strategies
The latest update is out from IKIO Lighting Limited ( ($IN:IKIO) ). IKIO Techno...
08-04 16:55
KION GROUP AG reports Q2 results, 2025 guidance
KION GROUP AG press release (OTCPK:KIGRY): Q2 revenue slightly down to €5.5B (H1 2024: €5.74B). More on KION GROUP AG KION: Upside After Q1 2025 Remains Solid, Despite Tariffs Historical earnings data...
07-30 23:17
Kiora Pharmaceuticals Granted U.S. Patent Expanding Protection For KIO-104 In The Treatment of Ocular Disease
Kiora Pharmaceuticals, Inc. (NASDAQ:KPRX) today announced it has received a patent (US Patent No. 12,364,680) covering KIO-104 for the treatment of a wide range of ocular diseases. This includes, but is not limited to,
07-22 21:09
公司簡介
公司名稱
|
KKR Income Opportunities Fund
|
行業分類
|
--
|
業務描述
|
KKR Income Opportunities Fund is a closed-end management investment company, which engages in the investments in bank loans and high yield securities. The company was founded on July 25, 2013 and is headquartered in San Francisco, CA.
|
TMT Notes | AI半导体/英伟达/Marvell/美光/存储/设备
（来源：纳指弹幕组） *原则: 定期更新, 专注美股TMT及配套供应链；仅转述归纳外资研报观点，不展示研报原文，保护研报版权；无精力做知识星球, 不...
09-28 20:45
KIO Data Centers积极支持太空数据存储
墨西哥及拉丁美洲的数字基础设施提供商KIO Data Centers宣布与天基数据存储先驱Lonestar Data Holdings建立战略联盟。此次合作开创...
09-22 11:13
KKR Income Opportunities Fund declares $0.1215 dividend
KKR Income Opportunities Fund (NYSE:KIO) declares $0.1215/share monthly dividend, in line with previous. Forward yield 11.6% Payable Oct. 31; for shareholders of record Oct. 10; ex-div Oct. 10. Payabl...
09-12 20:46
质变开启：潍柴动力(000338.SZ/2338.HK)2025中报里的转型与突围
2025年上半年，中国商用车行业在复杂多变的宏观环境中展现出强大的发展韧性，结束了此前连续几年的低迷期。从销量数据、政策支持到结构性调整，多维度指标均呈现显著回...
09-02 09:13
6家中国药企进入全球TOP50！云南白药、中生、华东、百济、恒瑞、石药
作者 | 晓琳 编辑 | 郑瑶 国内药企上榜数量创历史新高，云南白药、中国生物、华东医药、百济神州、恒瑞医药、石药集团。 01 全球制药企业50强 中国6家药...
08-20 18:53
KIOCL Limited Exits Export Oriented Unit Scheme
The latest announcement is out from KIOCL Ltd ( ($IN:KIOCL) ). KIOCL Limited ha...
08-11 15:36
Kiora Pharmaceuticals GAAP EPS of -$0.54
Kiora Pharmaceuticals press release (NASDAQ:KPRX): Q2 GAAP EPS of -$0.54. Ended the quarter with $20.7 million in cash, cash equivalents and short-term investments, along with $2.4 million in collabor...
08-08 19:09
IKIO Technologies Releases Investor Presentation to Outline Growth Strategies
The latest update is out from IKIO Lighting Limited ( ($IN:IKIO) ). IKIO Techno...
08-04 16:55
KION GROUP AG reports Q2 results, 2025 guidance
KION GROUP AG press release (OTCPK:KIGRY): Q2 revenue slightly down to €5.5B (H1 2024: €5.74B). More on KION GROUP AG KION: Upside After Q1 2025 Remains Solid, Despite Tariffs Historical earnings data...
07-30 23:17
Kiora Pharmaceuticals Granted U.S. Patent Expanding Protection For KIO-104 In The Treatment of Ocular Disease
Kiora Pharmaceuticals, Inc. (NASDAQ:KPRX) today announced it has received a patent (US Patent No. 12,364,680) covering KIO-104 for the treatment of a wide range of ocular diseases. This includes, but is not limited to,
07-22 21:09
派息除權日
|
每股總股息
| 派息日期 |
2025-12-12
|
0.12
|
2025-12-31
|
2025-11-14
|
0.12
|
2025-11-28
|
2025-10-10
|
0.12
|
2025-10-31
|
2025-09-12
|
0.12
|
2025-09-30
|
2025-08-08
|
0.12
|
2025-08-29
|
2025-07-11
|
0.12
|
2025-07-31
|
2025-06-13
|
0.12
|
2025-06-30
|
2025-05-09
|
0.12
|
2025-05-30
|
2025-04-11
|
0.12
|
2025-04-30
|
2025-03-14
|
0.12
|
2025-03-31
|
2025-02-06
|
0.12
|
2025-02-28
|
2025-01-10
|
0.12
|
2025-01-31
|
2024-12-13
|
0.12
|
2024-12-31
|
2024-11-08
|
0.12
|
2024-11-29
|
2024-10-11
|
0.12
|
2024-10-31
|
2024-09-13
|
0.12
|
2024-09-30
|
2024-08-09
|
0.12
|
2024-08-30
|
2024-07-12
|
0.12
|
2024-07-31
|
2024-06-14
|
0.12
|
2024-06-28
|
2024-05-09
|
0.12
|
2024-05-31
|
2024-04-11
|
0.12
|
2024-04-30
|
2024-03-14
|
0.12
|
2024-03-29
|
2024-02-15
|
0.12
|
2024-02-29
|
2024-01-11
|
0.12
|
2024-01-31
|
2023-12-14
|
0.12
|
2023-12-29
|
2023-11-09
|
0.12
|
2023-11-30
|
2023-10-12
|
0.12
|
2023-10-31
|
2023-09-07
|
0.12
|
2023-09-29
|
2023-08-10
|
0.12
|
2023-08-31
|
2023-07-13
|
0.12
|
2023-07-31
|
2023-06-08
|
0.12
|
2023-06-30
|
2023-05-11
|
0.12
|
2023-05-31
|
2023-04-13
|
0.12
|
2023-04-28
|
2023-03-09
|
0.12
|
2023-03-31
|
2023-02-02
|
0.10
|
2023-02-28
|
2023-01-12
|
0.10
|
2023-01-31
|
2022-12-08
|
0.10
|
2022-12-30
|
2022-11-09
|
0.10
|
2022-11-30
|
2022-10-13
|
0.10
|
2022-10-31
|
2022-09-08
|
0.10
|
2022-09-30
|
2022-08-11
|
0.10
|
2022-08-31
|
2022-07-14
|
0.10
|
2022-07-29
|
2022-06-09
|
0.10
|
2022-06-30
|
2022-05-12
|
0.10
|
2022-05-31
|
2022-04-14
|
0.10
|
2022-04-29
|
2022-03-10
|
0.10
|
2022-03-31
|
2022-02-10
|
0.10
|
2022-02-28
|
2022-01-13
|
0.10
|
2022-01-31
|
2021-12-09
|
0.10
|
2021-12-30
|
2021-11-10
|
0.10
|
2021-11-30
|
2021-10-14
|
0.10
|
2021-10-29
|
2021-09-09
|
0.10
|
2021-09-30
|
2021-08-12
|
0.10
|
2021-08-31
|
2021-07-08
|
0.10
|
2021-07-30
|
2021-06-10
|
0.10
|
2021-06-30
|
2021-05-13
|
0.10
|
2021-05-28
|
2021-04-08
|
0.10
|
2021-04-30
|
2021-03-11
|
0.10
|
2021-03-31
|
2021-02-11
|
0.10
|
2021-02-26
|
2021-01-14
|
0.10
|
2021-01-29
|
2020-12-10
|
0.10
|
2020-12-31
|
2020-11-12
|
0.10
|
2020-11-30
|
2020-10-08
|
0.13
|
2020-10-30
|
2020-09-10
|
0.13
|
2020-09-30
|
2020-08-13
|
0.13
|
2020-08-31
|
2020-07-09
|
0.13
|
2020-07-31
|
2020-06-11
|
0.13
|
2020-06-30
|
2020-05-14
|
0.13
|
2020-05-29
|
2020-04-08
|
0.13
|
2020-04-30
|
2020-03-12
|
0.13
|
2020-03-31
|
2020-02-13
|
0.13
|
2020-02-28
|
2020-01-09
|
0.13
|
2020-01-31
|
2019-12-12
|
0.13
|
2019-12-31
|
2019-11-14
|
0.13
|
2019-11-29
|
2019-10-10
|
0.13
|
2019-10-31
|
2019-09-12
|
0.13
|
2019-09-30
|
2019-08-08
|
0.13
|
2019-08-30
|
2019-07-11
|
0.13
|
2019-07-31
|
2019-06-13
|
0.13
|
2019-06-28
|
2019-05-09
|
0.13
|
2019-05-31
|
2019-04-11
|
0.13
|
2019-04-30
|
2019-03-14
|
0.13
|
2019-03-29
|
2019-02-14
|
0.13
|
2019-02-28
|
2019-01-10
|
0.13
|
2019-01-31
|
2018-12-13
|
0.13
|
2018-12-31
|
2018-11-08
|
0.13
|
2018-11-30
|
2018-10-11
|
0.13
|
2018-10-31
|
2018-09-13
|
0.13
|
2018-09-28
|
2018-08-09
|
0.13
|
2018-08-31
|
2018-07-12
|
0.13
|
2018-07-31
|
2018-06-14
|
0.13
|
2018-06-29
|
2018-05-10
|
0.13
|
2018-05-31
|
2018-04-12
|
0.13
|
2018-04-30
|
2018-03-08
|
0.13
|
2018-03-29
|
2018-02-08
|
0.13
|
2018-02-28
|
2018-01-11
|
0.13
|
2018-01-31
|
2017-12-28
|
0.05
|
2018-01-31
|
2017-12-14
|
0.13
|
2017-12-29
|
2017-11-03
|
0.13
|
2017-11-30
|
2017-10-05
|
0.13
|
2017-10-31
|
2017-09-15
|
0.13
|
2017-09-29
|
2017-08-10
|
0.13
|
2017-08-31
|
2017-07-13
|
0.13
|
2017-07-31
|
2017-06-08
|
0.13
|
2017-06-30
|
2017-05-11
|
0.13
|
2017-05-31
|
2017-04-13
|
0.13
|
2017-04-28
|
2017-03-09
|
0.13
|
2017-03-31
|
2017-02-09
|
0.13
|
2017-02-28
|
2017-01-12
|
0.13
|
2017-01-31
|
2016-12-28
|
0.09
|
2017-01-31
|
2016-12-08
|
0.13
|
2016-12-30
|
2016-11-09
|
0.13
|
2016-11-30
|
2016-10-13
|
0.13
|
2016-10-31
|
2016-09-08
|
0.13
|
2016-09-30
|
2016-08-11
|
0.13
|
2016-08-31
|
2016-07-14
|
0.13
|
2016-07-29
|
2016-06-09
|
0.13
|
2016-06-30
|
2016-05-12
|
0.13
|
2016-05-31
|
2016-04-14
|
0.13
|
2016-04-29
|
2016-03-10
|
0.13
|
2016-03-31
|
2016-02-11
|
0.13
|
2016-02-29
|
2016-01-13
|
0.13
|
2016-01-29
|
2015-12-10
|
0.13
|
2015-12-31
|
2015-11-12
|
0.13
|
2015-11-30
|
2015-10-08
|
0.13
|
2015-10-26
|
2015-09-10
|
0.13
|
2015-09-28
|
2015-08-13
|
0.13
|
2015-08-31
|
2015-07-09
|
0.13
|
2015-07-27
|
2015-06-11
|
0.13
|
2015-06-29
|
2015-05-14
|
0.13
|
2015-05-26
|
2015-04-16
|
0.13
|
2015-04-27
|
2015-03-12
|
0.13
|
2015-03-30
|
2015-02-05
|
0.13
|
2015-02-23
|
2015-01-08
|
0.13
|
2015-01-26
|
2014-12-26
|
0.15
|
2015-01-30
|
2014-12-11
|
0.13
|
2014-12-29
|
2014-11-13
|
0.13
|
2014-11-24
|
2014-10-08
|
0.13
|
2014-10-27
|
2014-09-11
|
0.13
|
2014-09-29
|
2014-08-14
|
0.13
|
2014-08-25
|
2014-07-10
|
0.13
|
2014-07-28
|
2014-06-12
|
0.13
|
2014-06-30
|
2014-05-15
|
0.13
|
2014-05-27
|
2014-04-16
|
0.13
|
2014-04-28
|
2014-03-13
|
0.13
|
2014-03-31
|
2014-02-06
|
0.13
|
2014-02-24
|
2014-01-09
|
0.13
|
2014-01-27
|
2013-12-26
|
0.16
|
2014-01-31
|
2013-12-12
|
0.13
|
2013-12-30
|
2013-11-06
|
0.13
|
2013-11-25
|
2013-10-09
|
0.13
|
2013-10-28
|
